Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8086 to 8100 of 8216 results

  1. Tideglusib for treating congenital or childhood onset myotonic dystrophy [ID3915 ]

    Awaiting development [GID-TA10791] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Robot-assisted surgery for soft-tissue procedures: early value assessment

    In development [GID-HTE10040] Expected publication date: 21 January 2025

    Health technology evaluations
    In development

  3. Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy TSID 12015

    Awaiting development [GID-TA11551] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. News

    NICE and NHS England announce plan to enable innovative tech to be adopted quicker NHS patients in England will benefit from faster

  5. Women's and reproductive health guidelines

    This webpage covers all NICE's guidelines on women's and reproductive health. The table presents the guidelines alphabetically. Updates planned or in...

    NICE guideline
    In development

  6. Depemokimab for treating severe eosinophilic asthma in people 12 years and over TSID 12017

    Awaiting development [GID-TA11553] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive B-precursor acute lymphoblastic leukaemia with no measurable residual disease ID6405

    In development [GID-HTE10035] Expected publication date: TBC

    Health technology evaluations
    In development

  8. NICE

    NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.

  9. Sirolimus for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older [ID6440]

    In development [GID-TA11554] Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Artificial intelligence (AI) technologies for assessing skin lesions referred on the urgent suspected cancer pathway

    In development [GID-HTE10047] Expected publication date: TBC

    Health technology evaluations
    In development

  11. Cabotegravir for preventing HIV-1 in adults and young people [ID6255]

    In development [GID-TA11304] Expected publication date: 13 November 2024

    Technology appraisal guidance
    In development

  12. Abaloparatide for treating osteoporosis in postmenopausal women [ID882]

    In development [GID-TA10071] Expected publication date: 07 August 2024

    Technology appraisal guidance
    In development

  13. Robot-assisted surgery for orthopaedic procedures: early value assessment

    In development [GID-HTE10043] Expected publication date: 21 January 2025

    Health technology evaluations
    In development

  14. Lutetium oxodotreotide with octreotide for newly diagnosed unresectable or metastatic gastroenteropancreatic neuroendocrine tumours [ID6315]

    Awaiting development [GID-TA11366] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Empagliflozin for preventing cardiovascular events after acute myocardial infarction [ID6240]

    In development [GID-TA11265] Expected publication date: TBC

    Technology appraisal guidance
    In development